Information:
Error:
ID
39741
Description
Miravirsen in Combination With Telaprevir and Ribavirin in Null Responder to Pegylated-Interferon Alpha Plus Ribavirin Subjects With Chronic Hepatitis C Virus Infection; ODM derived from: https://clinicaltrials.gov/show/NCT01872936
Link
https://clinicaltrials.gov/show/NCT01872936
Keywords
Versions (1)
- 2/14/20 2/14/20 -
Copyright Holder
See clinicaltrials.gov
Uploaded on
February 14, 2020
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Hepatitis C, Chronic NCT01872936
Eligibility Hepatitis C, Chronic NCT01872936
- StudyEvent: Eligibility
Similar models
Eligibility Hepatitis C, Chronic NCT01872936
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Chronic Hepatitis C Genotype
Item
diagnosis of chronic hepatitis c genotype 1 infection
boolean
C0524910 (UMLS CUI [1,1])
C1533728 (UMLS CUI [1,2])
C1533728 (UMLS CUI [1,2])
Body mass index
Item
bmi 18 and 38 kg/m2
boolean
C1305855 (UMLS CUI [1])
Non-responder Peginterferon alfa-2a | Non-responder Peginterferon alfa-2b | Non-responder Ribavirin
Item
null responder to pegylated interferon alpha and ribavirin
boolean
C0919875 (UMLS CUI [1,1])
C0391001 (UMLS CUI [1,2])
C0919875 (UMLS CUI [2,1])
C0796545 (UMLS CUI [2,2])
C0919875 (UMLS CUI [3,1])
C0035525 (UMLS CUI [3,2])
C0391001 (UMLS CUI [1,2])
C0919875 (UMLS CUI [2,1])
C0796545 (UMLS CUI [2,2])
C0919875 (UMLS CUI [3,1])
C0035525 (UMLS CUI [3,2])
HBV coinfection | Human immunodeficiency virus (HIV) coinfection
Item
co-infection with hepatitis b virus (hbv) or human immunodeficiency virus (hiv)
boolean
C2242656 (UMLS CUI [1])
C4062778 (UMLS CUI [2])
C4062778 (UMLS CUI [2])
Liver disease In addition to Hepatitis C
Item
significant liver disease in addition to hepatitis c
boolean
C0023895 (UMLS CUI [1,1])
C0332287 (UMLS CUI [1,2])
C0019196 (UMLS CUI [1,3])
C0332287 (UMLS CUI [1,2])
C0019196 (UMLS CUI [1,3])
Decompensated liver disease
Item
decompensated liver disease medical history or current clinical features
boolean
C4075847 (UMLS CUI [1])
Liver Cirrhosis
Item
histologic evidence of hepatic cirrhosis
boolean
C0023890 (UMLS CUI [1])
Comorbidity Clinical Significance | Exception Chronic Hepatitis C
Item
concurrent clinically significant medical diagnosis (other than chc)
boolean
C0009488 (UMLS CUI [1,1])
C2826293 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0524910 (UMLS CUI [2,2])
C2826293 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0524910 (UMLS CUI [2,2])
Social Conditions Concurrent | Drug abuse | Alcohol intake above recommended sensible limits | LIVING CONDITION POOR
Item
concurrent social conditions (e.g. drugs of abuse, alcohol excess, poor living accommodation)
boolean
C0037403 (UMLS CUI [1,1])
C0205420 (UMLS CUI [1,2])
C0013146 (UMLS CUI [2])
C0560219 (UMLS CUI [3])
C0745770 (UMLS CUI [4])
C0205420 (UMLS CUI [1,2])
C0013146 (UMLS CUI [2])
C0560219 (UMLS CUI [3])
C0745770 (UMLS CUI [4])
Illness Clinical Significance Recent
Item
clinically significant illness within 30 days preceding entry into the study
boolean
C0221423 (UMLS CUI [1,1])
C2826293 (UMLS CUI [1,2])
C0332185 (UMLS CUI [1,3])
C2826293 (UMLS CUI [1,2])
C0332185 (UMLS CUI [1,3])
Study Subject Participation Status | Investigational New Drugs
Item
participated in an investigational drug study within 30 days or 5 half-lives, whichever is longer, prior to the start of study medication
boolean
C2348568 (UMLS CUI [1])
C0013230 (UMLS CUI [2])
C0013230 (UMLS CUI [2])
Drug Allergy
Item
history of clinically significant allergic drug reactions
boolean
C0013182 (UMLS CUI [1])